Track: Clinical

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	S-15 - Symposium
Time:	14.00-15.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Brain-focussed treatments of depression
	Klaus Ebmeier, United Kingdom	Chair
	Thomas Schlaepfer, Germany	Co-Chair

001	New data on the mode of action of electroconvulsive therapy
	Allan Scott, United Kingdom	Speaker
002	New data on efficacy and safety of magnetic seizure therapy
	Mustafa Husain, USA	Speaker
003	New methodological developments in transcranial magnetic stimulation
	John Rothwell, United Kingdom	Speaker
004	New data on deep brain stimulation
	Thomas Schlaepfer, Germany	Speaker

No.	S-19 - Symposium
Time:	14.00-15.30
Room:	Room 351
Topic:	Neurodegenerative Disorders
Track:	2 Clinical
Session title:	Early diagnosis of Alzheimers disease
	Bruno Dubois, France	Chair
	Harald Hampel, Germany	Co-Chair

001	Clinical and prognostic heterogeneity of mild cognitive impairment
	Orestes V. Forlenza, Brazil	Speaker
002	The role CSF biomarkers in the identification of AD at pre-dementia stages
	Harald Hampel, Germany	Speaker
003	Imaging of amyloid-beta in Alzheimers disease
	Swen Hesse, Germany	Speaker
004	For a new concept and new criteria for the diagnosis of Alzheimer’s disease
	Bruno Dubois, France	Speaker

No.	S-22 - Symposium
Time:	16.00-17.30
Room:	Room 352AB
Topic:	Affective Disorders (Bipolar)
Track:	2 Clinical
Session title:	Suicide prevention: Focusing on modifiable risk factors
	Zoltan Rihmer, Hungary	Chair
	Hagop S. Akiskal, USA	Co-Chair

001	Prophylaxis of bipolar disorder
	Leonardo Tondo, USA	Speaker
002	Treatment of depression
	Zoltan Rihmer, Hungary	Speaker
003	Are sudden dips in mood the final common pathway of suicide?
	Hagop S. Akiskal, USA	Speaker
004	Are any of the biological substrates of suicidality modifiable?
	Leo Sher, USA	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	S-26 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Other
Track:	2 Clinical
Session title:	New approaches to diagnostics and treatment in personality disorders
	Sabine Herpertz, Germany	Chair
	Larry Siever, USA	Co-Chair

001	Changes in classifying personality disorders: New from the DSM-V task force
	Roel Verheul, Netherlands	Speaker
002	Schizotypal personality disorder: New data on imaging, genetics, and treatment
	Larry Siever, USA	Speaker
003	Differentiating subtypes of antisocial personality disorder by functional neuroimaging
	Sabine Herpertz, Germany	Speaker
004	Psychotherapeutic treatment guidelines in personality disorders
	Klaus Lieb, Germany	Speaker

No.	S-29 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Psychopharmacology
Track:	2 Clinical
Session title:	Antipsychotic treatment of aggression in the intellectually disabled - a growing controversy
	David Janowsky, USA	Chair
	Sherva Elizabeth Cooray, United Kingdom	Co-Chair

001	Antipsychotic withdrawal induced activation of aggression in the intellectually disabled
	David Janowsky, USA	Speaker
002	Evidence for the effectiveness of antipsychotic medications to manage problem behaviors in adults with intellectual disability
	Shoumitro Deb, United Kingdom	Speaker
003	Antipsychotic agents in the treatment of autism
	David Posey, USA	Speaker
004	The argument against antipsychotic agents in the intellectually disabled
	Sherva Elizabeth Cooray, United Kingdom	Speaker

No.	S-31 - Symposium
Time:	08.00-09.30
Room:	Room 251
Topic:	Childhood Adolescent Disorder
Track:	2 Clinical
Session title:	ADHD in adults: Comorbidity aspects and the therapeutic issues
	Joseph Biederman, USA	Chair
	Jacques Bouchez, France	Co-Chair

001	The 5-HTTLPR-S/s Genotype increases the risk for depression and anxiety disorders in youth with ADHD when exposed to parental depression: A gene-environment interaction study
	Joseph Biederman, USA	Speaker
002	Gender effect in response to methylphenidate treatment in adults with ADHD
	Thomas Spencer, USA	Speaker
003	Cigarette smoking and ADHD : A review and new pharmacotherapies perspectives
	Herve Caci, France	Speaker
004	Impulsivity in adult ADHD clinical subtypes
	Jacques Bouchez, France	Speaker

« previous day	Tuesday, 30. June 2009	next day »

No.	S-49 - Symposium
Time:	11.00-12.30
Room:	Salle Maillot
Topic:	Brain Function
Track:	2 Clinical
Session title:	Translational medicine in psychiatry; making sense of preclinical and clinical research: Methodologies, opportunities, and controversies
	Husseini Manji, USA	Chair
	Andrea De Bartolomeis, Italy	Co-Chair

001	Translational medicine of bipolar disorders
	Husseini Manji, USA	Speaker
002	Genetically determined dopamine signaling in schizophrenia phenotypes
	Alessandro Bertolino, Italy	Speaker
003	Major depressive disorder is a risk factor for osteoporosis in women
	Cizza Giovanni, USA	Speaker
004	Traslational studies and the search for new targets in psychosis treatment, methodology, success and failure
	Andrea De Bartolomeis, Italy	Speaker

No.	S-51 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	2 Clinical
Session title:	Cannabis: What's happening?
	Amine Benyamina, France	Chair
	Michel Reynaud, France	Co-Chair

001	Pharmacological treatment of cannabis dependence
	Margaret Haney, USA	Speaker
002	Cannabis and psychiatric co-morbidity
	Stanley Zammit, United Kingdom	Speaker
003	Cannabis: Legal aspects and decriminalisation
	Wim van den Brink, Netherlands	Speaker
004	Pharmacogenetic vulnerability
	Amine Benyamina, France	Speaker

No.	S-57 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Depression, vitamin D and light
	Witte Hoogendijk, Netherlands	Chair
	Consuelo Hopkins Wilkins, USA	Co-Chair

001	Vitamin D, light and parathyroid hormone in depression
	Witte Hoogendijk, Netherlands	Speaker
002	Positive effect of bright light in non-seasonal depression
	Ritsaert Lieverse, Netherlands	Speaker
003	Developmental vitamin D deficiency alters adult behaviour
	Thomas Burne, Australia	Speaker
004	Vitamin D deficiency is associated with low mood and worse cognitive performance
	Consuelo Hopkins Wilkins, USA	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	S-60 - Symposium
Time:	08.00-09.30
Room:	Blue Amphitheatre
Topic:	Anxiety
Track:	2 Clinical
Session title:	Disaster follow-up: International perspectives
	Joseph Zohar, Israel	Chair
	Manickam Thirunavukarasu, India	Co-Chair

001	9/11 – American insights
	Rachel Yehuda, USA	Speaker
002	1999 earthquake in Turkey – the lessons from a seven year follow-up
	Oguz Karamustafalioglu, Turkey	Speaker
003	Tsunami 2004 - retrospective introspection
	Manickam Thirunavukarasu, India	Speaker
004	Can PTSD be prevented?
	Joseph Zohar, Israel	Speaker

No.	S-62 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Neurodegenerative Disorders
Track:	2 Clinical
Session title:	Lithium, neuroprotection and dementia
	Wagner F. Gattaz, Brazil	Chair
	Husseini Manji, USA	Co-Chair

001	Neuroprotective effects of lithium: in vitro and in vivo models
	Husseini Manji, USA	Speaker
002	Does lithium protect against dementia? Evidence from clinical and genetic studies.
	Wagner F. Gattaz, Brazil	Speaker
003	Epidemiological evidence on the effects of lithium on the prevalence of dementia
	Lars Vedel Kessing, Denmark	Speaker
004	Lithium for the treatment of mild cognitive impairment: Preliminary results of a double-blind, placebo controlled trial
	Orestes V. Forlenza, Brazil	Speaker

No.	S-63 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Affective Disorders (Bipolar)
Track:	2 Clinical
Session title:	How far are we from reducing suicide in bipolar disorder?
	Frank Bellivier, France	Chair
	Eduard Vieta, Spain	Co-Chair

001	Suicidal risk in BP patients and bipolar risk in suicidal patients?
	Philippe Courtet, France	Speaker
002	Gene-environment interaction and the risk of suicidal behavior in bipolar patients
	Bruno Etain, France	Speaker
003	Psychosocial interventions in bipolar disorder: Impact on morbidity and mortality
	Francesc Colum, Spain	Speaker
004	Suicide prevention in bipolar patients
	Guy Goodwin, United Kingdom	Speaker

No.	S-74 - Symposium
Time:	16.00-17.30
Room:	Room 241
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	Chronobiological treatment combinations for major affective disorder: Clinical outcome and neurobiological correlates
	Anna Wirz-Justice, Switzerland	Chair
	Sylvie Royant-Parola, France	Co-Chair

001	Chronobiology as a paradigm for biological psychiatry
	Anna Wirz-Justice, Switzerland	Speaker
002	Nuts and bolts of chronotherapeutic interventions
	Michael Terman, USA	Speaker
003	Wake and light therapy in non-seasonal major depression
	Klaus Martiny, Denmark	Speaker
004	Wake and light therapy in bipolar illness: fMRI correlates of response
	Francesco Benedetti, Italy	Speaker

« previous day	Thursday, 2. July 2009

No.	S-78 - Symposium
Time:	08.00-09.30
Room:	Room 352AB
Topic:	Affective Disorders (Unipolar)
Track:	2 Clinical
Session title:	The emerging role of TMS in the treatment of psychiatric disorders
	Philip Janicak, USA	Chair
	Abraham Zangen, Israel	Co-Chair

001	Transcranial magnetic stimulation of deep brain regions: An overview and ongoing studies in psychiatric patients and healthy subjects
	Abraham Zangen, Israel	Speaker
002	Predictive factors and biomarkers for TMS in depression
	Jeffrey Rado, USA	Speaker
003	TMS for other neuropsychiatric disorders
	Eman Khedr, Egypt	Speaker
004	Efficacy of TMS for depression and review of large sham-controlled trial
	Philip Janicak, USA	Speaker

« Back

---